Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human oral squamous carcinoma cells KB and KB/VCR: In vitro and in vivo studies.

[1]  Hwa-Jin Chung,et al.  Wnt/β-Catenin Signaling Mediates the Antitumor Activity of Magnolol in Colorectal Cancer Cells , 2012, Molecular Pharmacology.

[2]  M. Rocchi,et al.  Characterization of a new trabectedin‐resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agents , 2012, International journal of cancer.

[3]  Xian-Jun Qu,et al.  Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: in vitro and in vivo studies. , 2012, Lung cancer.

[4]  Prabodh K. Kandala,et al.  Regulation of Janus-activated kinase-2 (JAK2) by diindolylmethane in ovarian cancer in vitro and in vivo. , 2012, Drug discoveries & therapeutics.

[5]  Y. Assaraf,et al.  Overcoming Multidrug Resistance via Photodestruction of ABCG2-Rich Extracellular Vesicles Sequestering Photosensitive Chemotherapeutics , 2012, PloS one.

[6]  H. Sui,et al.  Signal Transduction Pathways and Transcriptional Mechanisms of ABCB1/Pgp-mediated Multiple Drug Resistance in Human Cancer Cells , 2012, The Journal of international medical research.

[7]  H. Lou,et al.  Synthesis of macrocyclic bisbibenzyl derivatives and their anticancer effects as anti-tubulin agents. , 2012, Bioorganic & medicinal chemistry.

[8]  Zu-hua Gao,et al.  Inhibition of Intestinal Adenoma Formation in APCMin/ + Mice by Riccardin D, a Natural Product Derived from Liverwort Plant Dumortiera hirsuta , 2012, PloS one.

[9]  Xian-Jun Qu,et al.  A112, a tamibarotene dimethylaminoethyl ester, may inhibit human leukemia cell growth more potently than tamibarotene , 2012, Leukemia & lymphoma.

[10]  Zu-hua Gao,et al.  Riccardin D, a novel macrocyclic bisbibenzyl, induces apoptosis of human leukemia cells by targeting DNA topoisomerase II , 2012, Investigational New Drugs.

[11]  Qiang Zhang,et al.  Comparison of different methods for preparation of a stable riccardin D formulation via nano-technology. , 2012, International journal of pharmaceutics.

[12]  H. Lou,et al.  Overcoming of P-glycoprotein-mediated multidrug resistance in K562/A02 cells using riccardin F and pakyonol, bisbibenzyl derivatives from liverworts. , 2011, Bioscience trends.

[13]  Xian-Jun Qu,et al.  Inhibition of angiogenesis involves in anticancer activity of riccardin D, a macrocyclic bisbibenzyl, in human lung carcinoma. , 2011, European journal of pharmacology.

[14]  Jianwei Jiang,et al.  Sodium valproate induces mitochondria-dependent apoptosis in human hepatoblastoma cells. , 2011, Chinese medical journal.

[15]  G. Gao,et al.  Plasminogen K5 activates mitochondrial apoptosis pathway in endothelial cells by regulating Bak and Bcl-xL subcellular distribution , 2011, Apoptosis.

[16]  W. Yong,et al.  Upregulation of mdr1 gene is related to activation of the MAPK/ERK signal transduction pathway and YB-1 nuclear translocation in B-cell lymphoma. , 2011, Experimental hematology.

[17]  G. Singh,et al.  Nrf2-mediated protection against UVA radiation in human skin keratinocytes. , 2011, Bioscience trends.

[18]  H. Hong,et al.  Acquisition of chemoresistance in intrahepatic cholangiocarcinoma cells by activation of AKT and extracellular signal-regulated kinase (ERK)1/2. , 2011, Biochemical and biophysical research communications.

[19]  Bin Sun,et al.  Bisbibenzyl derivatives sensitize vincristine-resistant KB/VCR cells to chemotherapeutic agents by retarding P-gp activity. , 2010, Bioorganic & medicinal chemistry.

[20]  F. Estévez,et al.  5,7,3′‐trihydroxy‐3,4′‐dimethoxyflavone‐induced cell death in human Leukemia cells is dependent on caspases and activates the MAPK pathway , 2010, Molecular carcinogenesis.

[21]  J. Schellens,et al.  PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell line , 2009, Cancer Chemotherapy and Pharmacology.

[22]  H. Tilg,et al.  Knockdown of PgP resensitizes leukemic cells to proteasome inhibitors. , 2007, Biochemical and biophysical research communications.

[23]  H. Friess,et al.  Mitogen-activated protein kinases and chemoresistance in pancreatic cancer cells. , 2006, The Journal of surgical research.

[24]  Roger M Macklis,et al.  Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation , 2006, Nature chemical biology.

[25]  J. Oszmiański,et al.  In vitro antileukaemic activity of extracts from berry plant leaves against sensitive and multidrug resistant HL60 cells. , 2006, Cancer letters.

[26]  Seong-Jin Kim,et al.  Genipin-induced apoptosis in hepatoma cells is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of mitochondrial pathway. , 2005, Biochemical pharmacology.

[27]  Hui-Hsuan Lin,et al.  Induction of apoptosis in the lung tissue from rats exposed to cigarette smoke involves p38/JNK MAPK pathway. , 2005, Chemico-biological interactions.

[28]  D. Goldstein,et al.  Changes in epidermal growth factor receptor expression in human bladder cancer cell lines following interferon-alpha treatment. , 2004, The Journal of urology.

[29]  Martin Schuler,et al.  Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis , 2004, Science.

[30]  Z. Miao,et al.  Cytotoxicity, apoptosis induction and downregulation of MDR‐1 expression by the anti‐topoisomerase II agent, salvicine, in multidrug‐resistant tumor cells , 2003, International journal of cancer.

[31]  C. Dive,et al.  Mitochondrial membrane permeabilisation by Bax/Bak. , 2003, Biochemical and biophysical research communications.

[32]  P. Dennis,et al.  Activation of the PI3K/Akt pathway and chemotherapeutic resistance. , 2002, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[33]  B. Dörken,et al.  The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines , 2002, Oncogene.

[34]  Xian-Jun Qu,et al.  Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human hepatocellular carcinoma growth through induction of apoptosis in p53-dependent way. , 2013, Cancer letters.

[35]  Wei Li,et al.  The COX-2 inhibitor Celecoxib enhances the sensitivity of KB/VCR oral cancer cell lines to Vincristine by down-regulating P-glycoprotein expression and function. , 2012, Prostaglandins & other lipid mediators.